期刊文献+

人感染H7N9禽流感26例临床特征与病毒基因分析研究 被引量:7

Clinical features of 26 patients with H7N9 avian influenza and characteristics of viral gene
下载PDF
导出
摘要 目的探讨人感染H7N9禽流感病毒患者的流行病学和临床特征,以及病毒分子生物学特征。方法收集湖南省2013、2014年确诊的26例人感染H7N9禽流感病毒患者的资料,对人和禽分离的H7N9病毒进行鉴定和测序分析。结果26例患者中,发热和咳嗽是最常见的起病症状,所有患者均存在肺炎;20例(76.92%)出现急性呼吸窘迫综合征(ARDS),25例(96.15%)初诊时白细胞下降或正常,发病至开始进行抗病毒治疗的平均时间为10 d。10例死亡,病死率达38.46%。患者分离的H7N9病毒株测序分析表明,发生了H7基因Gln226Leu和Gly186Val替换,PB2基因Asp701Asn突变。结论急性呼吸系统损害是人感染H7N9禽流感的主要临床表现,活禽暴露是人感染H7N9禽流感的重要危险因素,H7N9禽流感病毒基因发生了部分位点的适应性突变,更容易从禽类向人跨种传播引起人类严重疾病,需加强病原学监测。 Objective To evaluate the clinical,epidemiological,and viral molecular biology features of 26 patients infected with H7N9 avian influenza A virus. Methods Clinical and epidemiological data of 26 patients with con-firmed avian influenza A (H7N9)infection in 2013 and 2014 were collected,virus isolated from human and poultry were identified and typed through sequencing.Results Of 26 patients,fever and cough were the most common symptoms,all patients had pneumonia;20 patients (76. 92% )developed acute respiratory distress syndrome (ARDS);25 patients (96.15% )had leucopenia or normal leukocytes at the initial diagnosis;treatment with antivi-ral drugs was initiated in 25 patients at a median of 10 days after the onset of illness;10 patients (38.46% )died. Gene sequencing indicated Gln226Leu and Gly186Val substitutions in human virus H7 gene and the PB2 Asp701Asn mutation. Conclusion Acute respiratory system damage is the main clinical manifestation of avian influenza (H7N9)virus infection in humans,live poultry exposure is an important risk factor for H7N9 infection in humans, adaptive mutation occurred at partial site of avian virus gene,which can be more easily be spread from birds to hu-man and cause serious diseases,it is necessary to strengthen the pathogen monitoring.
出处 《中国感染控制杂志》 CAS 北大核心 2015年第7期464-467,共4页 Chinese Journal of Infection Control
关键词 H7N9 禽流感 临床特征 禽流感病毒 基因突变 早期识别 avian influenza clinical feature avian influenza virus gene mutation early recognition
  • 相关文献

参考文献3

二级参考文献15

  • 1中华人民共和国卫生部.甲型H1N1流感诊疗方案(2009年第三版)[EB/OL].(2009-10-13)[2009-10-22].http://61.49.18.65/publicfiles/business/htmlfiles/mohyzs/s3586/200910/43111.htm.
  • 2Cao B,Li X-W,Mao Y,et al.Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China[J].N Engl J Med,2009,361 (26):2507-2517.
  • 3Moscona A.Global transmission of oseltamivir-resistant influenza[J].N Engl J Med,2009,360(10):953-956.
  • 4Garten R J,Davis C T,Russell C A,et al.Antigenic and genetic characteristics of swine-origin 2009 A (H1N1) influenza viruses circulating in humans[J].Science,2009,325 (5937):197-201.
  • 5Perez-Padilla R,de la Rosa-Zamboni D,Ponce de Leon S,et al.Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico[J].N Engl J Med,2009,361(7):680-689.
  • 6Treanor J J,Hayden F G,Vrooman P S,et al.Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza[J].JAMA,2000,283(8):1016-1024.
  • 7Nicholson K G,Aoki F Y,Osterhaus A D,et al.Efficacy and safety of the oseltamivir in treatment of acute influenza:a randornized controlled trial[J].Lancet,2000,355(9218):1845-1850.
  • 8Meier C R,Napalkov P N,Negmiileo Y,et al.Populationbased study on incidence,risk factors,clinical complications and drug utilization associated with influenza in the United Kingdom[J].Eur J Clin Microbiol Infect Dis,2000,19(11):834-842.
  • 9Kaiser L,Wat C,Mills T,et al.Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations[J].Arch Intern Med,2003,163(14):1667-1672.
  • 10Wetherall N T,Trivedi T,Zeller J,et al.Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors:report of the Neuraminidase Inhibitor Susceptibility Network[J].J Clin Microbiol,2003,41 (2):742-750.

共引文献377

同被引文献57

  • 1姜立民,高孟,罗永能.128例人感染H7N9禽流感流行病学分析[J].国际流行病学传染病学杂志,2013,40(3). 被引量:8
  • 2前田宁子,王静舒.流感病毒的分型及基因组结构[J].日本医学介绍,2004,25(9):387-389. 被引量:3
  • 3Philippe Gautret P,Gmy GC,et al.Emerging viral respiratory tract infections- environmental risk factors and transmission[J].The Lancet Infectious Diseases;2.014; 14,1113-1122.
  • 4A1-Tawfiq JA,Zumla A,Philippe Gautret P.Surveillanee for emerging respiratory viruses[J].The Lancet Infectious Diseases,2014.14, 992-1000.
  • 5Lam TrY,Wang J,Shen YG,et al.The genesis and source of the H7N9 influenza viruses causing human infections in China[J].Nature,2013,502:241-244.
  • 6Gao GF.Influenza and the Live Poultry Trade[J].Science,2014,344:235.
  • 7Gao R, Can B, Hu Y, et aL Human infection with a novel avian-orlgin influenza A (H7N9) virus. N Engl J Med 2013,368:1888-1897.
  • 8Li IW, Chart KH, To KW, et al. Differential susceptibility of different cell lines to swine-origin influenza A HIN1, seasousl human influenza A H1N1, and avian influenza A H5N1 viruses. J Clin Virol, 2009, 46:325-330.
  • 9Ranst MV, Lemey P. (2013) Genesis of avian--origin H7N9 influenza A viruses.The Lancet 381: 9881, 1883-1885.
  • 10Liu, D. et aL Origin and diversity of novel avian influenza A H7N9 viruses causing human infectlom phylogenellc, structural, and coalescent analyses. Lancet, 2013:381, 1926--1932.

引证文献7

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部